Novo Nordisk shares fall as Viatris fights Wegovy patents
JHVEPhoto Despite a recent rally, Novo Nordisk (NVO), Europe's second most valuable company, has underperformed in recent weeks as markets ...
JHVEPhoto Despite a recent rally, Novo Nordisk (NVO), Europe's second most valuable company, has underperformed in recent weeks as markets ...
The MIT School of Engineering and global healthcare company Novo Nordisk have announced the launch of a multi-year program to ...
Fotolia/iStock via Getty Images JPMorgan recently raised its projections for weight loss drugs, expecting the drug category known as GLP-1 ...